Clinical Trial Update: Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder

View source ↗

Summary

This clinical trial update reports the completed study evaluating the validity of a genetic risk assessment tool to identify Autism Spectrum Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder
• Developmental Delay

Snippet

Sponsor: Thomas W. Frazier, Ph.D | Conditions: Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder | Status: COMPLETED